Brief: Astonea Labs Buys 25.74% Equity Stake In Damaira Pharmaceuticals
31/03/2026 14:38
March 31 (Reuters) - Astonea Labs Ltd ASTD.BO: BUYS 25.74% EQUITY STAKE IN DAMAIRA PHARMACEUTICALS Source text: ID:nBSE3kJCc3 Further company coverage: ASTD.BO ((Reutersbriefs@thomsonreuters.com;))
Recent news on Astonea Labs
See all newsBrief: Astonea Labs Approves Incorporation Of Longevity Science As Unit Of Co
Brief: Astonea Labs Completes SBDMA Yemen Inspection Of Haryana Manufacturing Facility
Brief: Astonea Labs Says Inadvertent Fire Incident Took Place On 27Th April 2026
Brief: Astonea Labs Buys 25.74% Equity Stake In Damaira Pharmaceuticals
Brief: Astonea Labs Executes Sale Deed For Land Acquisition In Haryana